Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.

Fan D, Kang JJ, Fan M, Wang H, Lee A, Yu Y, Chen L, Jillian Tsai C, McBride SM, Riaz N, Gelblum DY, Neal BP, Fetten J, Dunn LA, Michel LS, Boyle JO, Cohen MA, Roman BR, Ganly I, Singh B, Wong RJ, Sherman EJ, Lee NY.

Oral Oncol. 2020 Mar 14;104:104641. doi: 10.1016/j.oraloncology.2020.104641. [Epub ahead of print]

PMID:
32182548
2.
3.

Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.

Fan M, Kang JJ, Lee A, Fan D, Wang H, Kitpanit S, Fox P, Sine K, Mah D, McBride SM, Tsai CJ, Riaz N, Dunn LA, Sherman EJ, Michel L, Singh B, Ganly I, Wong RJ, Boyle JO, Cohen MA, Lee NY.

Cancer. 2020 Feb 25. doi: 10.1002/cncr.32776. [Epub ahead of print]

PMID:
32097507
4.

Metabolomic identification of placental alterations in fetal growth restriction.

Bahado-Singh RO, Turkoglu O, Yilmaz A, Kumar P, Zeb A, Konda S, Sherman E, Kirma J, Allos M, Odibo A, Maulik D, Graham SF.

J Matern Fetal Neonatal Med. 2020 Feb 10:1-10. doi: 10.1080/14767058.2020.1722632. [Epub ahead of print]

PMID:
32041426
5.

Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers.

Subbiah V, Puzanov I, Blay JY, Chau I, Lockhart AC, Raje NS, Wolf J, Baselga J, Meric-Bernstam F, Roszik J, Diamond EL, Riely GJ, Sherman EJ, Riehl T, Pitcher B, Hyman DM.

Cancer Discov. 2020 Feb 6. pii: CD-19-1265. doi: 10.1158/2159-8290.CD-19-1265. [Epub ahead of print]

6.

Intervening on Network Ties.

Sherman E, Shpitser I.

Uncertain Artif Intell. 2019 Jul;2019. pii: 352.

7.

T Cell Activation through Isolated Tight Contacts.

Razvag Y, Neve-Oz Y, Sajman J, Yakovian O, Reches M, Sherman E.

Cell Rep. 2019 Dec 10;29(11):3506-3521.e6. doi: 10.1016/j.celrep.2019.11.022.

8.

Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14).

Lee A, Kang J, Yu Y, McBride S, Riaz N, Cohen M, Sherman E, Michel L, Lee N, Tsai CJ.

Int J Part Ther. 2019 Spring;5(4):1-10. doi: 10.14338/IJPT-19-00051.1. Epub 2019 Apr 22.

9.

Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinoma.

Groen AH, Beckham TH, Links TP, Goldman DA, Sherman EJ, Tuttle MM, Bijl HP, Wong RJ, Plukker JTM, Lee NY; and other Group/Consortium Members.

J Surg Oncol. 2019 Nov 16. doi: 10.1002/jso.25761. [Epub ahead of print]

PMID:
31733124
10.

Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Araten DJ, Boxer D, Zamechek L, Sherman E, Nardi M.

Blood Cells Mol Dis. 2020 Feb;80:102372. doi: 10.1016/j.bcmd.2019.102372. Epub 2019 Oct 18.

PMID:
31710879
11.

Addressing Profound Disadvantages to Improve Indigenous Health and Reduce Hospitalisation: A Collaborative Community Program in Remote Northern Territory.

Quilty S, Wood L, Scrimgeour S, Shannon G, Sherman E, Lake B, Budd R, Lawton P, Moloney M.

Int J Environ Res Public Health. 2019 Nov 6;16(22). pii: E4306. doi: 10.3390/ijerph16224306.

12.

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.

Dunn LA, Riaz N, Fury MG, McBride SM, Michel L, Lee NY, Sherman EJ, Baxi SS, Haque SS, Katabi N, Wong RJ, Xiao H, Ho AL, Pfister DG.

Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):564-570. doi: 10.1016/j.ijrobp.2019.09.050. Epub 2019 Oct 31.

PMID:
31678634
13.

Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy.

Beckham TH, Leeman JE, Xie P, Li X, Goldman DA, Zhang Z, Sherman E, McBride S, Riaz N, Lee N, Tsai CJ.

Br J Cancer. 2019 Nov;121(11):897-903. doi: 10.1038/s41416-019-0601-8. Epub 2019 Oct 25.

PMID:
31649318
14.

The RNA-binding protein SART3 promotes miR-34a biogenesis and G1 cell cycle arrest in lung cancer cells.

Sherman EJ, Mitchell DC, Garner AL.

J Biol Chem. 2019 Nov 15;294(46):17188-17196. doi: 10.1074/jbc.AC119.010419. Epub 2019 Oct 16.

PMID:
31619517
15.

Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.

Beckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Zhang Z, Lobaugh SM, Grecula JC, Mitchell DL, Wobb JL, Miller ED, Blakaj DM, Diavolitsis VM, Lee N, Bhatt AD.

Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32736. [Epub ahead of print]

PMID:
31609479
16.

Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.

Fan D, Ma J, Bell AC, Groen AH, Olsen KS, Lok BH, Leeman JE, Anderson E, Riaz N, McBride S, Ganly I, Shaha AR, Sherman EJ, Tsai CJ, Kang JJ, Lee NY.

Cancer. 2020 Jan 15;126(2):444-452. doi: 10.1002/cncr.32548. Epub 2019 Oct 8.

PMID:
31593317
17.

Dissecting the Antenna in Human Glutamate Dehydrogenase: Understanding Its Role in Subunit Communication and Allosteric Regulation.

Hoffpauir ZA, Sherman E, Smith TJ.

Biochemistry. 2019 Oct 15;58(41):4195-4206. doi: 10.1021/acs.biochem.9b00722. Epub 2019 Oct 7.

PMID:
31577135
18.

Identification of Personalized Effects Associated With Causal Pathways.

Shpitser I, Sherman E.

Uncertain Artif Intell. 2018 Aug;2018. pii: 198.

19.

The critical role of second-order normative beliefs in predicting energy conservation.

Jachimowicz JM, Hauser OP, O'Brien JD, Sherman E, Galinsky AD.

Nat Hum Behav. 2018 Oct;2(10):757-764. doi: 10.1038/s41562-018-0434-0. Epub 2018 Sep 17.

PMID:
31406290
20.

Observations of Shear Stress Effects on Staphylococcus aureus Biofilm Formation.

Sherman E, Bayles K, Moormeier D, Endres J, Wei T.

mSphere. 2019 Jul 17;4(4). pii: e00372-19. doi: 10.1128/mSphere.00372-19.

21.

Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection.

Band VI, Hufnagel DA, Jaggavarapu S, Sherman EX, Wozniak JE, Satola SW, Farley MM, Jacob JT, Burd EM, Weiss DS.

Nat Microbiol. 2019 Oct;4(10):1627-1635. doi: 10.1038/s41564-019-0480-z. Epub 2019 Jun 17.

PMID:
31209306
22.

Click Chemistry-Mediated Complementation Assay for RNA-Protein Interactions.

Sherman EJ, Lorenz DA, Garner AL.

ACS Comb Sci. 2019 Jul 8;21(7):522-527. doi: 10.1021/acscombsci.9b00071. Epub 2019 Jun 7.

PMID:
31181888
23.

Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.

Sherman EJ, Dunn LA, Schöder H, Ho AL, Baxi SS, Ghossein RA, Haque SS, Sima C, Tuttle RM, Pfister DG.

Cancer. 2019 Sep 1;125(17):2984-2990. doi: 10.1002/cncr.32046. Epub 2019 Jun 7.

PMID:
31174237
24.

Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction.

Bahado-Singh RO, Yilmaz A, Bisgin H, Turkoglu O, Kumar P, Sherman E, Mrazik A, Odibo A, Graham SF.

PLoS One. 2019 Apr 18;14(4):e0214121. doi: 10.1371/journal.pone.0214121. eCollection 2019.

25.

Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.

Tchekmedyian V, Sherman EJ, Dunn L, Tran C, Baxi S, Katabi N, Antonescu CR, Ostrovnaya I, Haque SS, Pfister DG, Ho AL.

J Clin Oncol. 2019 Jun 20;37(18):1529-1537. doi: 10.1200/JCO.18.01859. Epub 2019 Apr 2.

PMID:
30939095
26.

Effect of Health Insurance on Hepatitis C Sustained Virologic Response Rates to Sofosbuvir-Based Treatment Regimens in a South Florida Community Hospital.

Eckardt P, Niu J, Savage A, Griffin T, Sherman E.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219835590. doi: 10.1177/2325958219835590.

27.

Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

Brooks KM, Sherman EM, Egelund EF, Brotherton A, Durham S, Badowski ME, Cluck DB.

Pharmacotherapy. 2019 May;39(5):576-598. doi: 10.1002/phar.2246. Epub 2019 Apr 1. Review.

PMID:
30860610
28.

Solitons in Inhomogeneous Gauge Potentials: Integrable and Nonintegrable Dynamics.

Kartashov YV, Konotop VV, Modugno M, Sherman EY.

Phys Rev Lett. 2019 Feb 15;122(6):064101. doi: 10.1103/PhysRevLett.122.064101.

PMID:
30822068
29.

Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.

Sherman EX, Wozniak JE, Weiss DS.

Methods Mol Biol. 2019;1946:39-50. doi: 10.1007/978-1-4939-9118-1_4.

31.

Factor structure of the CNS Vital Signs computerized cognitive battery in youth with neurological diagnoses.

Brooks BL, Plourde V, Fay-McClymont TB, MacAllister WS, Sherman EMS.

Child Neuropsychol. 2019 Oct;25(7):980-991. doi: 10.1080/09297049.2019.1569609. Epub 2019 Jan 24.

PMID:
30676266
32.

The WISC-V in children and adolescents with epilepsy.

MacAllister WS, Maiman M, Vasserman M, Fay-Mcclymont T, Brooks BL, Sherman EMS.

Child Neuropsychol. 2019 Oct;25(7):992-1002. doi: 10.1080/09297049.2019.1571181. Epub 2019 Jan 24.

PMID:
30676259
33.

Identification and Estimation Of Causal Effects from Dependent Data.

Sherman E, Shpitser I.

Adv Neural Inf Process Syst. 2018 Dec;2018:9446-9457.

34.

Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature.

Beckham TH, Leeman J, Jillian Tsai C, Riaz N, Sherman E, Singh B, Lee N, McBride S, Higginson DS.

Head Neck. 2019 May;41(5):1418-1426. doi: 10.1002/hed.25577. Epub 2019 Jan 11.

PMID:
30633423
35.

Nanoscale Topography-Rigidity Correlation at the Surface of T Cells.

Razvag Y, Neve-Oz Y, Sherman E, Reches M.

ACS Nano. 2019 Jan 22;13(1):346-356. doi: 10.1021/acsnano.8b06366. Epub 2018 Dec 3.

PMID:
30485065
36.

Long-term quality of life in older patients with HPV-related oropharyngeal cancer.

Baxi SS, Cullen G, Xiao H, Atoria CL, Sherman EJ, Ho A, Lee NY, Elkin EB, Pfister DG.

Head Neck. 2018 Nov;40(11):2321-2328. doi: 10.1002/hed.25159. Epub 2018 Nov 13.

37.

Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease.

Graham SF, Rey NL, Ugur Z, Yilmaz A, Sherman E, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P.

Metabolites. 2018 Oct 31;8(4). pii: E71. doi: 10.3390/metabo8040071.

38.

An attentional blink in the absence of spatial attention: a cost of awareness?

Alef Ophir E, Sherman E, Lamy D.

Psychol Res. 2018 Sep 27. doi: 10.1007/s00426-018-1100-x. [Epub ahead of print]

PMID:
30264360
39.

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.

Dunn LA, Sherman EJ, Baxi SS, Tchekmedyian V, Grewal RK, Larson SM, Pentlow KS, Haque S, Tuttle RM, Sabra MM, Fish S, Boucai L, Walters J, Ghossein RA, Seshan VE, Ni A, Li D, Knauf JA, Pfister DG, Fagin JA, Ho AL.

J Clin Endocrinol Metab. 2019 May 1;104(5):1417-1428. doi: 10.1210/jc.2018-01478.

40.

InterCells: A Generic Monte-Carlo Simulation of Intercellular Interfaces Captures Nanoscale Patterning at the Immune Synapse.

Neve-Oz Y, Sajman J, Razvag Y, Sherman E.

Front Immunol. 2018 Sep 11;9:2051. doi: 10.3389/fimmu.2018.02051. eCollection 2018.

41.

Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.

Ma J, Lok BH, Zong J, Gutiontov SI, Cai X, Bell AC, Shcherba M, Xiao H, Sherman EJ, Tsai CJ, Riaz N, McBride SM, Cahlon O, Lee NY.

Int J Part Ther. 2018 Spring;4(4):10-19. doi: 10.14338/IJPT-18-00003.1.

42.

Synergizing superresolution optical fluctuation imaging with single molecule localization microscopy.

Schidorsky S, Yi X, Razvag Y, Sajman J, Hermon K, Weiss S, Sherman E.

Methods Appl Fluoresc. 2018 Sep 18;6(4):045008. doi: 10.1088/2050-6120/aadc2b.

PMID:
30132439
43.

Derivation of New Embedded Performance Validity Indicators for the Child and Adolescent Memory Profile (ChAMP) Objects Subtest in Youth with Mild Traumatic Brain Injury.

Brooks BL, MacAllister WS, Fay-McClymont TB, Vasserman M, Sherman EMS.

Arch Clin Neuropsychol. 2019 Jun 1;34(4):531-538. doi: 10.1093/arclin/acy068.

PMID:
30124740
44.

Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.

Anderson SE, Sherman EX, Weiss DS, Rather PN.

mSphere. 2018 Aug 15;3(4). pii: e00271-18. doi: 10.1128/mSphere.00271-18.

45.

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.

Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, Nanjangud G, Eng S, Bose P, Kuo F, Morris LGT, Landa I, Carrillo Albornoz PB, Riaz N, Nikiforov YE, Patel K, Umbricht C, Zeiger M, Kebebew E, Sherman E, Ghossein R, Fagin JA, Chan TA.

Cancer Cell. 2018 Aug 13;34(2):256-270.e5. doi: 10.1016/j.ccell.2018.07.002.

46.

Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.

Beckham TH, Romesser PB, Groen AH, Sabol C, Shaha AR, Sabra M, Brinkman T, Spielsinger D, McBride S, Tsai CJ, Riaz N, Tuttle RM, Fagin JA, Sherman EJ, Wong RJ, Lee NY.

Thyroid. 2018 Sep;28(9):1180-1189. doi: 10.1089/thy.2018.0214.

47.

Overcoming diagnostic and treatment challenges in uveitic glaucoma.

Sherman ER, Cafiero-Chin M.

Clin Exp Optom. 2019 Mar;102(2):109-115. doi: 10.1111/cxo.12811. Epub 2018 Jul 29. Review.

PMID:
30058082
48.

Targeting VEGF and EGFR: a combination worth re-exploring?

Tchekmedyian V, Sherman EJ.

Lancet Oncol. 2018 Aug;19(8):1007-1009. doi: 10.1016/S1470-2045(18)30377-2. Epub 2018 Jul 11. No abstract available.

PMID:
30001988
49.

Cetuximab-Associated Pneumatosis Intestinalis.

Sherman E, Ramadas P, Lemke S.

Am J Ther. 2019 Sep/Oct;26(5):e609-e610. doi: 10.1097/MJT.0000000000000811. No abstract available.

PMID:
29965806
50.

Using the Memory Validity Profile (MVP) to detect invalid performance in youth with mild traumatic brain injury.

Brooks BL, Sherman EMS.

Appl Neuropsychol Child. 2019 Oct-Dec;8(4):319-325. doi: 10.1080/21622965.2018.1476865. Epub 2018 Jul 2.

PMID:
29963927

Supplemental Content

Loading ...
Support Center